alzheimer's - myDSC

Resources for Professionals

Modeling the Impact of Research Investment on Down Syndrome–Associated Alzheimer’s Disease

Individuals with Down syndrome (DS) are living longer than they used to. This trend has…

Kim WarrenJanuary 19, 2024

Resources for Professionals

LuMind IDSC Statement on FDA Approval of Leqembi

Last week the FDA announced a full approval of a new drug called Leqembi to…

Kim WarrenJuly 13, 2023

Health and Research – Alzheimer's/Dementia

Alzheimer’s Disease Video Journal

In September 2017, the Adult Down Syndrome Center started filming a video journal with Colleen,…

Kim WarrenJune 13, 2023

Health and Research – Alzheimer's/Dementia

Alzheimer’s Disease Story

The stories linked below were developed to help individuals with Down syndrome understand what Alzheimer's disease is…

Kim WarrenJune 6, 2023

Ask Dr. Brian Chicoine Health and Research – Alzheimer's/Dementia Health and Research – Other

Seizures, Alzheimer’s Disease

Question: My son is 59 years old and was diagnosed with Alzheimer’s probably in March…

Capetivate capetivateDecember 30, 2022

Resources for Professionals

Cross-Sectional Exploration of Plasma Biomarkers of Alzheimer’s Disease in Down Syndrome: Early Data from the Longitudinal Investigation for Enhancing Down Syndrome Research (LIFE-DSR) Study

With improved healthcare, the Down syndrome (DS) population is both growing and aging rapidly. However,…

Rigsby RigsbyMay 3, 2022

Health and Research – Alzheimer's/Dementia

How is Alzheimer’s disease diagnosed in a person with Down syndrome?

Alzheimer’s disease is a progressive neurological condition. It is a type of dementia. Alzheimer’s disease…

Rigsby RigsbyMarch 8, 2022

Health and Research – Alzheimer's/Dementia

The State of Alzheimer’s Research, with Dr Marcia Ratner & Dr James Hendrix

Dr. Marcia Ratner & Dr. James Hendrix discuss recent developments in Alzheimer’s research.Source: Dr. Marcia…

Rigsby RigsbyDecember 3, 2021

Health and Research – Alzheimer's/Dementia

Why Patient Voices Are So Critical to the Development and Initial Approval of New Drugs

This blogpost from a former FDA insider on the power of the patient helps us…

Rigsby RigsbyOctober 27, 2021

Health and Research – Alzheimer's/Dementia

Biogen Announces New Hope for Alzheimer’s Drug Candidate Aducanumab

On October 22, 2019, the biopharmaceutical company, Biogen, announced that they will be going to…

Rigsby RigsbyOctober 27, 2021

alzheimer’s

Modeling the Impact of Research Investment on Down Syndrome–Associated Alzheimer’s Disease

LuMind IDSC Statement on FDA Approval of Leqembi

Alzheimer’s Disease Video Journal

Alzheimer’s Disease Story

Seizures, Alzheimer’s Disease

Cross-Sectional Exploration of Plasma Biomarkers of Alzheimer’s Disease in Down Syndrome: Early Data from the Longitudinal Investigation for Enhancing Down Syndrome Research (LIFE-DSR) Study

How is Alzheimer’s disease diagnosed in a person with Down syndrome?

The State of Alzheimer’s Research, with Dr Marcia Ratner & Dr James Hendrix

Why Patient Voices Are So Critical to the Development and Initial Approval of New Drugs

Biogen Announces New Hope for Alzheimer’s Drug Candidate Aducanumab

CONTACT LUMIND IDSC

QUICK LINKS

JOIN US